# Correction: Girard et al. Comparative Efficacy of Neoadjuvant Nivolumab Plus Chemotherapy versus Conventional Comparator Treatments in Resectable Non-Small-Cell Lung Cancer: A Systematic Literature Review and Network Meta-Analysis. Cancers 2024, 16, 2492

**Authors:** Nicolas Girard, Mariam Besada, Basia Rogula, Stefano Lucherini, Lien Vo, Mohammad A. Chaudhary, Sarah Goring, Greta Lozano-Ortega, Mia Tran, Nebibe Varol, Nathalie Waser, Winifred W. Yu, Jay M. Lee, Jonathan Spicer

PMC · DOI: 10.3390/cancers17040674 · Cancers · 2025-02-17

## Full-text entities

- **Diseases:** Non-Small-Cell Lung Cancer (MESH:D002289), Cancers (MESH:D009369)
- **Chemicals:** Nivolumab (MESH:D000077594)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11840796/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC11840796/full.md

---
Source: https://tomesphere.com/paper/PMC11840796